Iron Deficiency Anemia (IDA)
13
2
4
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
31%
4 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (13)
Nutritional Educational Program On Therapy in Iron Deficiency Anemia
Management of Iron Deficiency Anemia in Hemodialysis Patients
A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia
Treadmill Aerobic Training and Quality of Life in Anemic Females
Collegiate Athlete Study
Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron
Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women
Patient Blood Management in Patients Scheduled for Cardiac Surgery
A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA
Community Interventions to Improve Iron and Iodine Status in Mother and Child Dyads in Northern Ghana
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
Directly Observed Iron Supplementation to Treat Anemia